Fritextsökning
Innehållstyper
-
Come see us at the upcoming events!
We have some upcoming events where you can see our latest products live!
-
Sobis läkemedel för blödarsjuka får grönt ljus i EU
Det svenska särläkemedelsbolaget Sobi har fått ett positivt omdöme i EU för sin nya behandling mot hemofili A. I ett utlåtande från den europeiska läkemedelsmyn...
-
Tredje gästprofessorn för klimatet
Klimatforskaren Keri Facer blir Uppsala universitets tredje gästprofessor på Zennströms klimatprofessur med inriktning klimatledarskap.
-
JMP Statistical Discovery
-
Assignment: Facilitate the retention of foreign researchers
A newly appointed public inquiry is to develop measures to make attracting and retaining foreign doctoral students and researchers in Sweden easier.
-
New Horizons in Biologics & Bioprocessing: Copenhagen 2026
-
Automated dispensing of liquids
Have a look at how you can do easier and faster dispensing on the fly adapted to your needs
-
ZEISS Microscope has been Optimized for Capturing Subcellular Structures and their Dynamics
Live imaging with uniform super-resolution in all spatial dimensions.
-
The life science strategy – what the industry wants
The process of updating the national life science strategy has begun at the government’s life science office. According to industry stakeholders, Sweden’s compe...
-
TFS Trial Form Support AB
-
Webinar: How to Plan And Analyze a Real-World Evidence Study
This webinar is for drug developers who want to understand the basic ideas of analyzing an RWE study, as well as avoiding the most common pitfalls.
-
Study: Vaccination linked to lower risk of post-COVID
The risk of developing post-COVID after a COVID infection was reduced in vaccinated people, according to a new study from the University of Gothenburg.
-
Festo AB
-
Eternal Rye – Improving Plant Breeding Methods
User story from Martin Luther University Halle.
-
Recipharm divests five Swedish plants
Swedish contract manufacturer Recipharm is selling its facilities in Solna, Strängnäs, Höganäs, Karlskoga and Uppsala OTC Development to US private equity compa...
-
“What is important is to create an overview and understanding from different perspectives”
Scientist Jochen Schwenk analyses blood proteins using proteomics to improve our understanding of disease and health. This year, he is moderating the Lab & Diag...
-
Settlement of cancer allegations against blockbuster drug
French pharmaceutical company Sanofi has reached a principal agreement in the US on around 4,000 of the cases in which its now withdrawn blockbuster heartburn d...
-
It couldn’t be simpler
AI-assisted ZEISS Solution inspects implant coatings automatically.
-
Ranking: Top 10 highest-paid CEOs in pharma
It's nice to hear that things go well for others, right? Some of those who have done really well – at least financially – are listed here in the ranking of the ...
-
Venom from the deathstalker carries radiopharmaceuticals to the brain
In order to target cancerous brain tumours with radionuclides, the problematic blood-brain barrier must first be crossed. Life Science Sweden has visited a KI r...
-
Lucy Robertshaw: Artificial intelligence – is this really going to transform a patient’s life?
In a column Lucy Robertshaw reflects on how AI and new regulations will affect healthcare, innovation and the lives of future patients.
-
“Don’t postpone the transition to IVDR”
Operators who have not yet started to adapt to the requirements of the new EU IVDR regulation are running out of excuses. This is the opinion of Helena Dzojic, ...
-
Emerson
-
Medicon Village Science Park